Author Archives: Editorial Staff

Recap - This week at PropThink we published Mr. Deryugin's assessment of a recently released draft bill, the 21st Century Cures Act, that could profoundly change the way many drugs are evaluated and approved by the FDA.

Recap - The range that had dominated trading in the S&P 500 for all of 2015 (which we wrote about last weekend) finally came to an end this Friday (the … Continue Reading

Recap - Despite a tumultuous five weeks, the market is entirely unchanged for 2015. Yes, Friday's close puts the S&P 500 flat from the beginning of the year.